Inhibition of Superantigen-Induced Proinflammatory Cytokine Production and Inflammatory Arthritis in MRL-Ipr/Ipr Mice by a Transcriptional Inhibitor of TNF-α

Journal of Immunology

Volumn 157, Issue 4, 1996, Pages 1758-1772

  Edwards III, Carl K ^a,d   Zhou, Tong ^b   Zhang, Jun ^a,e   Baker, Tari J ^a   De, Mamata ^a   Long, Richard E ^a   Borcherding, David R ^a   Bowlin, Terry L ^a   Bluethmann, Horst ^c   Mountz, John D ^b  

^a SANOFI   (France)

^b University of Alabama at Birmingham   (United States)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d AMGEN INC   (United States)

^e PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CYTOKINE; ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL; FAS ANTIGEN; HLA ANTIGEN CLASS 2; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; SUPERANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

AGING; ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; GLOMERULONEPHRITIS; IMMUNOLOGY; INFECTIOUS ARTHRITIS; METABOLISM; MOUSE; MOUSE MUTANT; PERITONEUM MACROPHAGE; PHYSIOLOGY; PROTEIN DENATURATION;

AGING; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; ANTIGENS, CD95; ARTHRITIS, INFECTIOUS; AUTOIMMUNE DISEASES; CELLS, CULTURED; CYTOKINES; ENTEROTOXINS; GLOMERULONEPHRITIS; HISTOCOMPATIBILITY ANTIGENS CLASS II; MACROPHAGES, PERITONEAL; MICE; MICE, MUTANT STRAINS; PROTEIN DENATURATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SUPERANTIGENS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030586573     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (97)

1. + T cells in lpr/lpr mice. J. Exp. Med. 172:1805.
2. Koopman, W. J., and S. Gay. 1988. The MRL-lpr/lpr mouse: a model for the study of rheumatoid arthritis. Scand. J. Rheumatol. 75 (Suppl. 1):284.
3. Cohen, P. L., and R. A. Eisenberg. 1991. lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
4. Mountz, J. D., T. Zhou, R. E. Long, H. Bluethmann, W. J. Koopman, and C. K. Edwards III. 1994. T cell influence on superantigen-induced arthritis in MRL-lpr/lpr mice. Arthritis Rheum. 37:113.
5. Sieper, J., and G. H. Kingsley. 1996. Recent advances in the pathogenesis of reactive arthritis. Immunol. Today 17:160.
6. Goodacre, J. A., C. E. D. Brownlie, and D. A. Ross. 1994. Bacterial superantigens in autoimmune disease. Br. J. Rheumatol. 33:413.
7. Abdelnour, A., T. Bremell, R. Holmdahl, and A. Tarkowski. 1994. Clonal expansion of T-lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1 producing staphylococci. Eur. J. Immunol. 24: 1161.
8. Taurog, J. D., J. A. Richardson, J. T. Croft, W. A. Simmons, M. Zhou, J. L. Fernandez-Sueiro, E. Balish, and R. E. Hammer. 1994. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180:2359.
9. Friedman, S. M., J. R. Tumang, and M. K. Crow. 1993. Microbial superantigens as etiopathogenic agents in autoimmunity. Rheum. Dis. Clin. North Am. 19:207.
10. Watanabe-Fukunaga, R., C. I. Branna, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in fas antigen that mediates apoptosis. Nature 356:314.
11. Nagata, S., and P. Golstein. 1995. The fax death factor. Science 267:1449.
12. Cheng, J., C. Liu, W. J. Koopman, and J. D. Mountz. 1995. Characterization of human fas gene: exon/intron organization and promoter region. J. Immunol. 154: 1239.
13. Wu, J., T. Zhou, J. He, and J. D. Mountz. 1993. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178:461.
14. Wu, J., T. Zhou, J. Zhang, J. He, W. C. Gause, and J. D. Mountz. 1994. Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc. Natl. Acad. Sci. USA 91:2344.
15. + T cells in MRL-lpr/lpr mice: clues from a T cell receptor β transgenic mouse. J. Immunol. 150:3651.
16. Strasser, A. 1995. Apoptosis: death of a T cell. Nature 373:385.
17. Mountz, J. D., J. Wu, J. Cheng, and T. Zhou. 1994. Autoimmune disease: a problem of defective apoptosis. Arthritis Rheum. 10:1415.
18. Chu, J. L., P. Ramos, A. Rosendorff, J. Nikolic-Zugic, E. Lacy, A. Matsuzawa, and K. B. Elkon. 1995. Massive up-regulation of the fas ligand in lpr and gld mice: implications for fas regulation and the graft-versus-host defense like wasting syndrome. J. Exp. Med. 181:393.
19. Sclomchik, M. J., M. P. Madaio, D. Ni, M. Trounstein, and D. Huszar. 1994. The role of B cells in lpr/lpr-induced autoimmunity. J. Exp. Med. 180:1295.
20. Simon, A. K., E. Seipelt, and J. Sieper. 1994. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc. Natl. Acad. Sci. USA 91:8562.
21. Levine, J. S., B. J. Pugh, D. Hartwell, J. M. Fitzpatrick, A. Marshak-Rothstein, and D. I. Beller. 1993. Interleukin-1 dyregulation is an intrinsic defect in macrophages from MRL autoimmune-prone mice. Eur. J. Immunol. 23:2951.
22. Suzuki, H., K. Yasukama, T. Saito, M. Narazaki, A. Hasegawa, T. Taga, and T. Kishimoto. 1993. Serum soluble interleukin-6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin-6 signal. Eur. J. Immunol. 23: 1078.
23. Mountz, J. D., and C. K. Edwards III. 1992. Murine models of autoimmune disease. Curr. Opin. Rheumatol. 4:621.
24. Lu, C. Y., and E. R. Unanue. 1987. Spontaneous T-cell lymphokine production and enhanced macrophage Ia expression and tumoricidal activity in MRL-lpr mice. Clin. Immunol. Immunopathol. 25:213.
25. Ohteki, T., S. Okamoto, M. Nakamura, E. Nemoto, and K. Kumagai. 1993. Elevated production of interleukin-6 by hepatic MNC correlates with ICAM-1 expression on the hepatic sinusoidal endothelial cells in autoimmune MRL/lpr mice. Immunol. Lett. 36:145.
26. Yui, M. A., W. H. Brissette, D. C. Brennan, R. P. Wuthrich, and V. E. Rubin-Kelley. 1991. Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-lpr mice. Am. J. Pathol. 139:255.
27. Kanno, H., O. Tachiwaki, M. Nose, and M. Kyogoku. 1994. Immune complex-degradation ability of macrophages in MRL-Mp-lpr/lpr lupus mice and its regulation by cytokines. Clin. Exp. Immunol. 95:115.
28. Ding, A., S. Hwang, and R. Schwab. 1994. Effect of aging on murine macrophages: diminished response to IFN-γ for enhanced oxidative metabolism. J. Immunol. 153:2146.
29. Boswell, J. M., M. A. Yui, D. W. Burt, and V. E. Kelley. 1988. Increased tumor necrosis factor and IL-1β nephritis. J. Immunol. 141:3050.
30. + T cells from young and old mice. J. Immunol. 150:3602.
31. Van Beuningen, H. M., I. J. Arntz, and W. B. van den Berg. 1991. In vivo effects of interleukin-1 on articular cartilage: prolongation of proteoglycan metabolic disturbances in old mice. Arthritis Rheum. 34:606.
32. Holmdahl, R., A. Tarkowsi, and R. Jonsson. 1991. Involvement of macrophages and dendritic cells in synovial inflammation of collagen induced arthritis in DBA/1 mice and spontaneous arthritis in MRL/lpr mice. Autoimmunity 8:271.
33. Murray, L., and C. Martens. 1989. The abnormal T lymphocytes in lpr mice transcribe interferon-γ and tumor necrosis factor-α genes spontaneously in vivo. Eur. J. Immunol. 19:563.
34. Mori, K., S. Kobayashi, M. Inobe, W.-Y. Jia, M. Tamakoshi, T. Miyazaki, and T. Uede. 1994. In vivo cytokine gene expression in various T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse. Autoimmunity 17:49.
35. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand. Cell 76:969.
36. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959.
37. Kayagaki, N., A. Kawasaki, T. Ebata, H. Ohmoto, S. Ikeda, S. Inoue, K. Yoshino, K. Okumura, and H. Yagita. 1995. Metalloproteinase-mediated release of human fas ligand. J. Exp. Med. 182:1777.
38. Tanaka, M., T. Suda, K. Haze, N. Nakamura, K. Sato, F. Kimura, K. Motoyoshi, M. Mizuki, S. Tagawa, S. Ohga, K. Hataka, A. H. Drummond, and S. Nagata. 1996. Fas ligand in human serum. Nature Med. 2:317.
39. Bradshaw, M., M. Rutherford, L. B. Schook, D. R. Borcherding, C. D. McWhinney, B. J. Hoeper, and C. K. Edwards III. 1995. Specific transcriptional inhibition of bone-marrow-derived macrophage (BMDMφ) TNF-α gene expression and protein production using novel enantiomeric carbocyclic nucleoside analogues. J. Pharmacol. Exp. Ther. 273:1506.
40. Mountz, J. D., T. J. Baker, D. R. Borcherding, H. Bluethmann, T. Zhou, and C. K. Edwards III. 1995. Increased susceptibility of fas mutant MRL-lpr/lpr mice to staphylococcal enterotoxin B-induced septic shock. J. Immunol. 155:4829.
41. Liu, C., J. Cheng, and J. D. Mountz. 1995. Differential expression of human fas mRNA species upon peripheral blood mononuclear cell activation. Biochem. J. 31:957.
42. Borcherding, D. R., N. P. Peet, H. R. Munson, P. F. Hoffman, H. Wynberg, E. van Echten, W. ten Hoeve, T. L. Bowlin, and C. K. Edwards III. 1996. Carbocyclic nucleosides as inhibitors of human tumor necrosis factor-alpha production: effects of the stereoisomers of 3-hydroxycyclopentyladenines. J. Med. Chem. In press.
43. SAS. 1995. Statistical Analytical Software. Cary, NC.
44. Mountz, J. D., T. Zhou, H. Bluethmann, J. Wu, and C. K. Edwards III. 1994. Apoptosis defect analyzed in TCR transgenic and for transgenic lpr mice. Int. Immunol. 11:321.
45. Mountz, J. D., and C. K. Edwards III. 1992. Murine models of autoimmunity: T cell and B cell defects. Curr. Opin. Rheumatol. 4:612.
46. 1 hybrids. J. Autoimmun. 4:595.
47. Watson, M. L., J. K. Rao, G. S. Gilkeson, P. Ruiz, E. M. Eicher, D. S. Pisetsky, A. Matsuzawa, J. M. Rochell, and M. F. Seldin. 1992. Genetic analysis of MRL-lpr/lpr mice: relationship of the fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 176:1645.
48. Elliott, M. J., R. N. Maini, M. Feldmann, J. R. Kalden, C. Antoni, J. S. Smolen, B. Loeb, F. C. Breedveld, J. P. MacFarlane, H. Bijl, and J. N. Woody. 1994. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor-α (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105.
49. Kim, C., K. A. Siminovitch, and A. Ochi. 1991. Reduction of lupus nephritis in MRL/lpr mice by a bacterial superantigen treatment. J. Exp. Med. 174:1431.
50. Gonzalo, J. A., R. Tarazona, H. J. Schurmon, F. Uytedehaag, G. Wick, C. Martinez-A., and G. Kroemer. 1994. A single injection of Staphylococcus aureus enterotoxin B reduces autoimmunity in MRL/lpr mice. Clin. Immunol. Immunopathol. 71:176.
51. Zhou, T., H. Bluethmann, J. Zhang, C. K. Edwards III, and J. D. Mountz. 1992. Defective maintenance of T cell tolerance to a superantigen in MRL-lpr/lpr mice. J. Exp. Med. 176:1063.
52. Zhou, T., C. Weaver, P. S. Linsley, and J. D. Mountz. 1994. T cells of staphylococcal enterotoxin B tolerized autoimmune MRL-lpr/lpr mice require costimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the TCR in the absence of this costimulatory signal. Eur. J. Immunol. 24:1019.
53. Edwards, C. K., III, T. Zhou, J. Zhang, C. D. McWhinney, T. L. Bowlin, and J. D. Mountz. 1993. Elevated proinflammatory cytokine production by macrophages obtained from MRL-lpr/lpr autoimmune mice correlates to defective fas antigen gene expression. Arthritis Rheum. 36:561 (Abstr.).
54. Mourad, W., K. Mehindate, T. J. Schall, and S. R. McColl. 1992. Engagement of major histocompatibility complex class II molecules by superantigen induces inflammatory cytokine gene expression in human rheumatoid fibroblast-like synoviocytes. J. Exp. Med. 175:613.
55. Zhou, T., C. K. Edwards III, P. Yang, Z. Wang, H. Bluethmann, and J. D. Mountz. 1996. Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor I. J. Immunol. 156:2661.
56. De Alboran, I. M., J. A. Gonzalo, G. Kroemer, E. Leonardo, M. A. R. Marcos, and C. Martinez-A. 1992. Attenuation of autoimmune disease and lymphocyte accumulation in MRL/lpr mice by treatment with anti-Vβ8 antibodies. Eur. J. Immunol. 22:2153.
57. Cullen, C. M., P. F. Bonventre, H. Heeg, H. Bluethmann, J. D. Mountz, and C. K. Edwards III. 1996. A fas antigen receptor mutation allows development of toxic shock syndrome toxin-1-induced lethal shock in Vβ8.2 T-cell receptor transgenic mice. Pathobiology. In press.
58. Marrack, P., M. Blackman, E. Kushnir, and S. Kappler. 1990. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp. Med. 171: 445.
59. Zhou, T., C. K. Edwards III, and J. D. Mountz. 1995. Prevention of age-related T cell apoptosis defect in CD2-fas transgenic mice. J. Exp. Med. 182:129.
60. Reap, E. A., D. Leslie, M. Abrams, R. A. Eisenberg, and P. L. Cohen. 1995. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice. J. Immunol. 154:956.
61. Zhou, T., C. K. Edwards III, H. Bluethmann, and J. D. Mountz. 1996. fas and tumor necrosis factor-receptor I-mediated activation-induced cell death of macrophages. FASEB J. 9:A352.
62. + lymphocytes delete activated macrophages through the fas/APO-1 antigen pathway. Proc. Natl. Acad. Sci. USA 92:11225.
63. Mehindate, K., R. Al-Daacak, L. Ricels, S. Mecheri, J. Hebert, and W. Mourad. 1994. Modulation of Mycoplosma arthritidis-derived superantigen-induced cytokine gene expression by dexamethasone and interleukin-4. Infect. Immun. 62: 4716.
64. Bhardwaj, N., A. S. Hodtsev, A. Nisanian, S. Kabak, S. M. Friedmann, B. C. Cole, and D. N. Posnett. 1994. Human T-cell responses to Mycoplasma arthritidis-derived superantigen. Infect. Immun. 62:135.
65. Scott, D. E., W. J. Kisch, and A. D. Steinberg. 1993. Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice. J. Immunol. 150:664.
66. + T cells in staphylococcus enterotoxin B-primed mice. J. Exp. Med. 172:1065.
67. McCormack, J. E., J. E. Callahan, J. Kappler, and P. C. Marrack. 1993. Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J. Immunol. 150:3785.
68. Sundstedt, A., M. Dohlsten, G. Hedlund, I. Hoiden, M. Bjorklund, and T. Killand. 1994. Superantigens anergize cytokine production but not cytotoxicity in vivo. Immunology 82:117.
69. Koesling, M., O. Rott, and B. Fleischer. 1994. Macrophages are dispensible for superantigen-mediated stimulation and anergy induction of peripheral T cells in vivo. Cell. Immunol. 157:29.
70. Gonzalo, J. A., E. Baixeras, A. Gonzalez-Garcia, A. George-Chandy, N. V. Rooijen, C. Martinez-A., and G. Kroemer. 1994. Differentiated in vivo effects of a superantigen and an antibody targeted to the same T cell receptor: activation-induced cell death vs passive macrophage-dependent depletion. J. Immunol. 152: 1597.
71. Ochi, A., K. Yuh, and K. Migita. 1993. Not every superantigen induces tolerance in vivo. Semin. Immunol. 5:57.
72. Lorenz, H. M., C. Antoni, T. Valerius, R. Repp, M. Grunke, N. Schwerdtner, H. Nusslein, J. Woody, J. R. Kalden, and B. Manger. 1996. In vivo blockade of TNF-α by intravenous infusion of a chimeric monoclonal TNF-α antibody in patients with rheumatoid arthritis: short term cellular and molecular effects. J. Immunol. 156:1646.
73. Mossman, T. R. 1994. Properties and functions of interleukin-10. Adv. Immunol. 56:1.
74. Katsikis, P. D., C. Q. Chu, F. M. Brennan, R. N. Maini, and M. Feldmann. 1994. Immunoregulatory role of interleukin-10 in rheumatoid arthritis. J. Exp. Med. 179:1517.
75. Cush, J. J., J. B. Splawashi, R. Thomas, J. E. McFarlin, H. Schulze-Koops, L. S. Davis, K. Fujjita, and P. E. Lipsky. 1995. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum. 38:96.
76. de Alboran, I. M., J. A. Gonzalo, G. Kroemer, E. Leonardo, M. A. R. Marcos, and C. Martinez-A. 1992. Attenuation of autoimmune disease and lymphocyte accumulation in MRL/lpr mice by treatment with anti-Vβ8.2 antibodies. Eur. J. Immunol. 22:2153.
77. Edwards, C. K., III, T. Zhou, J. Zhang, R. E. Long, D. R. Borcherding, and J. D. Mountz. 1992. Use of disease-modifying agents to elucidate pathogenic mechanisms in superantigen-induced arthritis in Vβ8.2 T cell receptor transgenic MRL-lpr/lpr mice. J. Cell. Biochem. 16:46 (Abstr.).
78. Hayashi, Y., H. Hamano, N. Haneji, N. Ishimaru, and K. Yanagi. 1995. Biased T cell receptor Vβ gene usage during specific stages of the development of autoimmune sialadenitis in the MRL/lpr mouse model of Sjogrens syndrome. Arthritis Rheum. 38:1077.
79. Schwab, J. H., R. R. Brown, S. K. Anderle, and P. M. Schlievert. 1993. Superantigens can reactivate bacterial cell wall-induced arthritis. J. Immunol. 150: 4151.
80. Migita, K., and A. Ochi. 1993. The fate of anergic T cells in vivo. J. Immunol. 150:763.
81. Muller, M., A. Emmendorffer, and M. L. Lohman-Matthes. 1991. Expansion and high proliferative potential of the macrophage system throughout life time of lupus-prone NZB/W and MRL-lpr/lpr mice: lack of down-regulation of extramedullar macrophage proliferation in the postnatal period. Eur. J. Immunol. 21:2211.
82. Emmendorffer, A., M. Muller, D. Wedekind, K. Hartung, and M. L. Lohman-Mathes. 1993. Expansion of the liver-associated macrophage system in systemic lupus erythematosus-prone NZB/W mice. J. Leukocyte Biol. 53:294.
83. Su, X., T. Zhou, C. Liu, J. P. Shapiro, M. J. Brauer, M. C. Kiefer, P. J. Barr, and J. D. Mountz. 1994. Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks fas-mediated apoptosis. Immunity 2:353.
84. Munn, D. H., A. C. Beale, D. Sarg, R. W. Wrenn, and D. C. Throckmorton. 1995. Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony stimulating factors and interferon-γ. J. Exp. Med. 181:127.
85. Kobayashi, S., T. Hirano, M. Kakinuma, and T. Uede. 1993. Transcriptional repression and differential splicing of fas mRNA by early transposon (ETn) insertion in autoimmune lpr mice. Biochem. Biophys. Res. Commun. 191:617.
86. Reiner, N. E. 1994. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol. Today 15:374.
87. Wang, S.-D., K.-J. Huang, Y.-S. Lin, and H.-Y. Lei. 1994. Sepsis-induced apoptosis of the thymocytes in mice. J. Immunol. 152:5014.
88. Florquin, S., Z. Amraoui, D. Abramowicz, and M. Goldman. 1994. Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J. Immunol. 153:2618.
89. D'Andréa, A., X. Ma, M. A.-Amezaga, C. Paganin, and G. Trinchieri. 1995. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the induction of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor-α production. J. Exp. Med. 181:537.
90. Lowrance, J. H., F. X. O'Sullivan, T. E. Caver, W. Waegell, and H. D. Gresham. 1994. Spontaneous elaboration of transforming growth factor β suppresses host defense against bacterial infection in autoimmune MRL/lpr mice. J. Exp. Med. 180:1693.
91. Takahashi, S., L. Fossati, M. Iwamoto, R. Merino, R. Motta, T. Kobayakawa, and S. Izui. 1996. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J. Clin. Invest. 97:1597.
92. Arend, W. P., and J. M. Dayer. 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor-α in rheumatoid arthritis. Arthritis Rheum. 38:151.
93. Fagiolo, U., A. Cossarizza, E. Scala, E. Fanales-Belasio, C. Ortolani, E. Cozzi, D. Monti, C. Franceschi, and R. Paganelli. 1993. Increased cytokine production in mononuclear cells of healthy elderly people. Eur. J. Immunol. 23:2375.
94. Riancho, J. A., M. T. Zarrabeitia, J. A. Amado, J. M. Oimos, and J. Macias-Gonzalez. 1994. Age-related differences in cytokine secretion. Gerontology 40:8.
95. 3 receptor agonist. Arthritis Rheum. 38:3401 (Abstr.).
96. 3 receptors on macrophages inhibits tumor necrosis factor-α. Eur. J. Pharmacol. In press.
97. 3 adenosine receptors. J. Immunol. 156:3435.